Kwality Pharmaceuticals Limited (BOM:539997)
India · Delayed Price · Currency is INR 3,645.05
-44.60 (-1.21%)
At close: Nov 6, 2026
Kwality Pharmaceuticals Market Cap
Kwality Pharmaceuticals has a market cap or net worth of 37.82 billion as of November 6, 2026. It is the 15,766th most valuable company in the world and the 960th biggest in India. Its market cap has increased by 305.82% in one year.
Market Cap
37.82B
Enterprise Value
39.08B
Revenue
5.54B
Global Rank
Country Rank
#960 India
PE Ratio
46.67
ChartMarket Cap Chart
Since July 18, 2016, Kwality Pharmaceuticals's market cap has increased from 230.87M to 37.82B, an increase of 16,282.25%. That is a compound annual growth rate of 63.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 37.82B | 228.87% |
| Dec 31, 2025 | 11.50B | 27.87% |
| Dec 31, 2024 | 8.99B | 116.81% |
| Dec 29, 2023 | 4.15B | 5.27% |
| Dec 30, 2022 | 3.94B | -58.55% |
| Dec 31, 2021 | 9.51B | 1,561.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bliss GVS Pharma | 67.07B |
| FDC Limited | 63.76B |
| Morepen Laboratories | 53.04B |
| Gufic Biosciences | 43.65B |
| Evonile Pharma | 42.33B |
| SHUKRA MEDTECH LIMITED | 35.13B |
| Unichem Laboratories | 34.75B |
| Hikal | 27.24B |